Skip to main content
Livermore
Livermore
ZHEN

First Light Asset Management, LLC

SEC CIK
0001600004
Latest filing
Aug 14, 2026

Holdings in Q4 2021

Holdings as of Dec 31, 2021, filed Feb 14, 2022. Long positions only; changes compare share counts with Q3 2021.

Institution overview
Positions
79
−4 vs. Q3 2021
Portfolio value
$1.40B
−$121.4M (−8.0%) vs. Q3 2021
Filed
Feb 14, 2022
SEC
Holdings of First Light Asset Management, LLC in Q4 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
SPNESeaSpine Holdings CorpCOM6,506,038$88.6M6.3%+242,778+3.9%AddedHistory
PRTAProthena Corp Public Ltd CoSHS1,622,941$80.2M5.7%+173,447+12.0%AddedHistory
MODNModel N, Inc.COM2,547,930$76.5M5.5%+69,398+2.8%AddedHistory
ATRCAtriCure, Inc.COM1,004,989$69.9M5.0%+357,797+55.3%AddedHistory
TNDMTandem Diabetes Care IncCOM NEW411,784$62.0M4.4%−67,402−14.1%ReducedHistory
BCYCBicycle Therapeutics PLCSPONSORED ADS1,000,783$60.9M4.4%+268,052+36.6%AddedHistory
HALOHalozyme Therapeutics, Inc.COM1,511,843$60.8M4.4%+34,347+2.3%AddedHistory
ARNAArena Pharmaceuticals IncCOM NEW645,848$60.0M4.3%−3140.0%ReducedHistory
OMCLOmnicell, Inc.COM304,895$55.0M3.9%−49,147−13.9%ReducedHistory
KRYSKrystal Biotech, Inc.COM680,170$47.6M3.4%+46,689+7.4%AddedHistory
XENTIntersect ENT, Inc.COM1,697,834$46.4M3.3%−438,989−20.5%ReducedHistory
KRTXKaruna Therapeutics, Inc.COM281,701$36.9M2.6%+6,057+2.2%AddedHistory
RAREUltragenyx Pharmaceutical Inc.COM411,313$34.6M2.5%−29,846−6.8%ReducedHistory
CDXSCodexis, Inc.COM1,089,150$34.1M2.4%+389,434+55.7%AddedHistory
STROSutro Biopharma, Inc.COM2,246,588$33.4M2.4%+55,149+2.5%AddedHistory
KROSKeros Therapeutics, Inc.COM552,098$32.3M2.3%+378,888+218.7%AddedHistory
HCATHealth Catalyst, Inc.COM813,046$32.2M2.3%+18,086+2.3%AddedHistory
CDNACareDx, Inc.COM683,463$31.1M2.2%−217,007−24.1%ReducedHistory
LITSLite Strategy, Inc.COM NEW11,217,426$30.0M2.1%+2,579,951+29.9%AddedHistory
CUTRCutera IncCOM656,873$27.1M1.9%−111,854−14.6%ReducedHistory
ATECAlphatec Holdings, Inc.COM NEW2,325,485$26.6M1.9%+550,817+31.0%AddedHistory
TPTXTurning Point Therapeutics, Inc.COM549,626$26.2M1.9%+96,748+21.4%AddedHistory
NEONeogenomics IncCOM NEW763,907$26.1M1.9%−292,053−27.7%ReducedHistory
AXGNAxogen, Inc.COM2,285,373$21.4M1.5%+46,112+2.1%AddedHistory
OPRXOptimizeRx CorpCOM NEW313,769$19.5M1.4%−193,615−38.2%ReducedHistory
INSMINSMED IncCOM PAR $.01698,369$19.0M1.4%−528,914−43.1%ReducedHistory
Bellus Health Inc New07987C204COM NEW2,326,528$18.7M1.3%+2,326,528New–
KRMDKORU Medical Systems, Inc.COM5,514,106$16.5M1.2%+105,680+2.0%AddedHistory
SIBNSI-BONE, Inc.COM720,243$16.0M1.1%+14,561+2.1%AddedHistory
TEVATeva Pharmaceutical Industries LtdSPONSORED ADS1,897,506$15.2M1.1%−725,525−27.7%ReducedHistory
KIDSOrthopediatrics CorpCOM237,385$14.2M1.0%+4,893+2.1%AddedHistory
FNAParagon 28, Inc.COM722,841$12.8M0.9%+722,841NewHistory
MXCTMaxcyte, Inc.COM1,232,277$12.6M0.9%+237,607+23.9%AddedHistory
PHLTPerformant Healthcare IncCOM4,886,173$11.8M0.8%+448,243+10.1%AddedHistory
BMRNBiomarin Pharmaceutical IncCOM127,785$11.3M0.8%−48,774−27.6%ReducedHistory
Itamar Med Ltd465437101SPONSORED ADS355,410$11.0M0.8%−307,559−46.4%Reduced–
NGMNGM Biopharmaceuticals IncCOM570,898$10.1M0.7%+570,898NewHistory
QDELQuidelOrtho CorpCOM74,544$10.1M0.7%+1,534+2.1%AddedHistory
PFEPfizer IncStock144,497$8.53M0.6%+136,028+1,606.2%AddedHistory
MRTXMirati Therapeutics, Inc.COM55,024$8.07M0.6%+55,024NewHistory
CRNXCrinetics Pharmaceuticals, Inc.COM272,796$7.75M0.6%+272,796NewHistory
AXNXAxonics, Inc.COM135,752$7.60M0.5%−206,073−60.3%ReducedHistory
AKUAkumin Inc.COM3,666,648$6.42M0.5%+106,737+3.0%AddedHistory
GMABGenmab A/SSPONSORED ADS158,947$6.29M0.5%−100,044−38.6%ReducedHistory
SIENProject Sage Oldco, Inc.COM1,608,349$5.90M0.4%+30,587+1.9%AddedHistory
ANNXAnnexon, Inc.COM473,700$5.44M0.4%−10,073−2.1%ReducedHistory
PLRXPliant Therapeutics, Inc.COM386,896$5.22M0.4%+386,896NewHistory
Abcam PLC000380204ADS219,285$5.16M0.4%+219,285New–
NARIInari Medical, Inc.Stock44,547$4.07M0.3%+32,813+279.6%AddedHistory
MRVIMaravai Lifesciences Holdings, Inc.COM CL A96,637$4.05M0.3%−22,066−18.6%ReducedHistory
JYNTJOINT CorpCOM55,452$3.64M0.3%−73−0.1%ReducedHistory
SLPSimulations Plus, Inc.COM75,023$3.55M0.3%−100−0.1%ReducedHistory
MIROMiromatrix Medical Inc.COM488,092$2.29M0.2%+13,092+2.8%AddedHistory
LHCGLHC Group, IncCOM15,219$2.09M0.1%−40−0.3%ReducedHistory
AVTRAvantor, Inc.COM14,596$615.0K<0.1%00.0%UnchangedHistory
SYNHSyneos Health, Inc.CL A5,736$589.0K<0.1%00.0%UnchangedHistory
ELVElevance Health, Inc.Stock1,244$577.0K<0.1%00.0%UnchangedHistory
WATWaters CorpCOM1,536$572.0K<0.1%00.0%UnchangedHistory
CVSCVS Health CorpStock5,519$569.0K<0.1%00.0%UnchangedHistory
GSKGSK plcSPONSORED ADR12,574$555.0K<0.1%00.0%UnchangedHistory
UTHRUnited Therapeutics CorpCOM2,466$533.0K<0.1%00.0%UnchangedHistory
NVSTEnvista Holdings CorpCOM11,793$531.0K<0.1%00.0%UnchangedHistory
BAXBaxter International IncStock5,929$509.0K<0.1%00.0%UnchangedHistory
ABBVAbbVie Inc.Stock3,740$506.0K<0.1%00.0%UnchangedHistory
ITGRInteger Holdings CorpCOM5,846$500.0K<0.1%00.0%UnchangedHistory
HUMHumana IncStock1,068$495.0K<0.1%00.0%UnchangedHistory
GILDGilead Sciences, Inc.Stock6,705$487.0K<0.1%00.0%UnchangedHistory
ICUIIcu Medical IncCOM2,039$484.0K<0.1%00.0%UnchangedHistory
BDXBecton Dickinson & CoStock1,888$475.0K<0.1%00.0%UnchangedHistory
BMYBristol Myers Squibb CoStock7,256$452.0K<0.1%00.0%UnchangedHistory
HOLXHologic IncCOM5,845$447.0K<0.1%00.0%UnchangedHistory
CICigna GroupStock1,943$446.0K<0.1%00.0%UnchangedHistory
NUVANuvasive IncCOM7,850$412.0K<0.1%00.0%UnchangedHistory
PRGOPERRIGO Co plcSHS9,823$382.0K<0.1%00.0%UnchangedHistory
JNJJohnson & JohnsonStock2,161$370.0K<0.1%00.0%UnchangedHistory
TAKTakeda Pharmaceutical Co LtdADR25,630$349.0K<0.1%00.0%UnchangedHistory
MCKMcKesson CorpStock1,346$335.0K<0.1%00.0%UnchangedHistory
SNYSanofiSPONSORED ADR6,650$333.0K<0.1%00.0%UnchangedHistory
UHSUniversal Health Services IncCL B2,050$266.0K<0.1%00.0%UnchangedHistory

Sold out since Q3 2021 (11)

Positions held at the end of Q3 2021 that are gone from this filing.

Positions of First Light Asset Management, LLC sold out since Q3 2021
SecurityClassShares in Q3 2021Value in Q3 2021% of portfolio in Q3 2021History
ALDXAldeyra Therapeutics, Inc.COM2,985,712$26.2M1.7%History
State Street SPDR S&P Biotech ETF78464A870ETF204,600$25.7M1.7%–
YMABY-mAbs Therapeutics, Inc.COM577,663$16.5M1.1%History
STIMNeuronetics, Inc.COM1,458,818$9.57M0.6%History
APTOAptose Biosciences Inc.COM NEW4,128,443$9.00M0.6%History
WWWW International, Inc.COM458,273$8.36M0.6%History
NVTAInvitae CorpCOM256,367$7.29M0.5%History
TCRRTCR2 Therapeutics Inc.COM620,887$5.28M0.3%History
RLAYRelay Therapeutics, Inc.COM51,848$1.64M0.1%History
HRCHill-Rom Holdings, Inc.COM4,346$652.0K<0.1%History
EBSEmergent BioSolutions Inc.COM4,294$215.0K<0.1%History